Key Takeaway from the Oncology Drug Pipeline

Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, discusses the rapidly changing oncology market and what to look for in the drug pipeline. 


This is a rapidly changing market. So as we prepare to look at what’s happening in oncology right here today and we looking into the future, we’re looking maybe 1 year out. But if we look at what we were looking at a year ago, it’s changed. So this is a rapidly changing market. We’ll continue to look at approvals much, much earlier. And one thing that’s important in the space is to look at biosimilars and specialty generics, along with how we’ve always monitored the pipeline for the oncology agents.

Related Articles

Research may lead to potential new targets for preventing cancer in humans.
Study suggests future interventions targeting improvements in cancer screenings may need to focus on the time of day when a patient visits a doctor.
Top news of the week from Specialty Pharmacy Times.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.